Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online May 1, 2020.
Article Versions
- You are currently viewing a previous version of this article (May 1, 2020 - 11:16).
- View the most recent version of this article
Copyright & Usage
Copyright © 2020 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
Author Information
- Thijs S. Stutvoet1,
- Elly L. van der Veen1,
- Arjan Kol1,
- Ines F Antunes2,
- Erik F.J. de Vries1,
- Geke A.P. Hospers1,
- Elisabeth G.E. de Vries1,
- Steven de Jong1 and
- Marjolijn N. Lub-de Hooge1
- 1 University Medical Center Groningen, University of Groningen, Netherlands;
- 2 University of Groningen, University Medical Center Groningen, Netherlands
- For correspondence or reprints contact: Marjolijn N. Lub-de Hooge, University Medical Center Groningen, University of Groningen, Hanzeplein1, Groningen 9713 GZ, Netherlands. E-mail: m.n.de.hooge@umcg.nl
Statistics from Altmetric.com
Cited By...
Article usage
In this issue
Jump to section
Related Articles
Cited By...
- 89Zr-DFO-Durvalumab PET/CT Before Durvalumab Treatment in Patients with Recurrent or Metastatic Head and Neck Cancer
- Optimizing Immuno-PET Imaging of Tumor PD-L1 Expression: Pharmacokinetic, Biodistribution, and Dosimetric Comparisons of 89Zr-Labeled Anti-PD-L1 Antibody Formats
- 18F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study